FDA Inspection 747382 — Rhode Island Blood Center, A Division of New York Blood Center, Inc.

Rhode Island Blood Center, A Division of New York Blood Center, Inc. — FEI 1270007

The FDA completed an inspection of Rhode Island Blood Center, A Division of New York Blood Center, Inc. on September 27, 2011 in Providence, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Providence, RI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
15521 CFR 606.160(b)Required records